share_log

港股异动 | 圣诺医药-B(02257)尾盘跌超8%创新低 年内股价已跌去八成 总市值不足5亿港元

HKEX Alert | Sanofi-B (02257) fell more than 8% at the end of the day, hitting a new low with a 80% drop in stock price since the beginning of the year and a total market value of less than HKD 500 million.

Zhitong Finance ·  Jun 18 15:26

Sanofi-B (02257) fell more than 8% in the final trading session and hit a new low of HKD 5.3 since its listing. The stock price has fallen by more than 84% since the beginning of this year, and the total market value is now less than HKD 500 million.

According to the Wisdom Wealth App, Sanofi-B (02257) fell more than 8% in the final trading session and hit a new low of HKD 5.3 since its listing. The stock price has fallen by more than 84% since the beginning of this year, and the total market value is now less than HKD 500 million. As of press time, it falls 8.05% to HKD 5.37 with a turnover of HKD 11.8668 million.

On the news front, earlier this month, Sanofi announced that Chief Medical Officer Francois Lebel and Chief Financial Officer Ye Yongji had both resigned. Previously, on May 17, Dr. Dai Xiaochang, the company's chief strategy officer, also resigned for personal reasons. It is worth noting that in April of this year, the company announced that it had received a written reply from the US FDA regarding the C-class meeting required for its core variety STP705, and has started the required preclinical studies according to the guidance of the FDA. The financial report shows that Sanofi has only about USD 23.88 million in cash at the end of 2023. As of now, Sanofi has not yet had any products commercialized.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment